Search Filters

Search Results

Found 32 results

510(k) Data Aggregation

    K Number
    K132208
    Manufacturer
    Date Cleared
    2014-04-10

    (268 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    SCENTED OR SCENTED-DEODORIZED MENSTRUAL TAMPON Classification Name: Classification Regulation: 21 CFR 884.5460
    |
    | Regulation
    Number | 21 CFR PART 884.5460
    Trade/Device Name: ONTEX SCENTED DIGITAL AND PLASTIC APPLICATOR TAMPONS Regulation Number: 21 CFR§ 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Scented Digital and Plastic Applicator Tampons are inserted into the vagina to absorb menstrual discharge.

    Device Description

    The Scented Tampons are:

    1. Scented Digital
    2. Scented Plastic Applicator (full size (long) and compact)
      They are scented versions because of the presence of a fragrance.
      Both the Applicator and Digital Tampons are inserted into the vagina to absorb menstrual discharge.
      These tampons, both the digital types and the applicator types will be provided with 4 absorbencies: light (
    AI/ML Overview

    The provided document describes a 510(k) submission for "ONTEX SCENTED DIGITAL AND PLASTIC APPLICATOR TAMPONS". This is a medical device application for tampons, not a diagnostic or AI-driven device. Therefore, the typical acceptance criteria and study designs involving performance metrics like sensitivity, specificity, MRMC studies, and ground truth establishment, which are relevant to image analysis or diagnostic algorithms, are not applicable here.

    Instead, the acceptance criteria for this type of device focus on biocompatibility and microbiology to ensure safety and substantial equivalence to a predicate device.

    Here's a breakdown of the requested information based on the provided text, while noting the different nature of this device:


    1. Table of acceptance criteria and the reported device performance

    Acceptance Criteria CategorySpecific Acceptance Criteria (Demonstrated)Device Performance (Reported)
    BiocompatibilityNon-cytotoxicPassed (non-cytotoxic)
    Non-irritantPassed (non-irritant), no terminal or gross observations in reproductive tracts of animals, no toxic signs, negligible dermal response.
    No potential for dermal irritationPassed (no potential for dermal irritation)
    No potential for allergic contact sensitizationPassed (no potential for allergic contact sensitization)
    MicrobiologyDoes not enhance growth of Staphylococcus aureusPassed (does not enhance growth of Staphylococcus aureus)
    Does not increase production of Toxic Shock Syndrome Toxin-1 (TSST-1)Passed (does not increase production of TSST-1)
    No effect on culture pHPassed (no effect on culture pH)
    Does not alter growth of normal vaginal microfloraPassed (does not alter growth of normal vaginal microflora)
    Voluntary Standards ComplianceComplies with applicable voluntary standards for biocompatibilityPassed all testing in accordance with national and international standards.
    Substantial EquivalenceDifferences from predicate device do not raise concerns regarding safety and effectivenessDemonstrated through biocompatibility and microbiological studies that the scented tampon is substantially equivalent in terms of biocompatibility, microbiological, and safety aspects.

    2. Sample size used for the test set and the data provenance

    The document does not specify sample sizes for specific tests. The tests appear to be laboratory-based and conducted on the materials or final product. The provenance of the data is from ONTEX BVBA, Belgium, as stated in the submission sponsor information. The studies are non-clinical performance data, likely conducted prospectively as part of the device development and submission process.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This concept is not applicable to the non-clinical testing performed for this device. Ground truth, in the context of device performance, typically refers to expert consensus or pathology for diagnostic devices. For biocompatibility and microbiological testing, standardized laboratory protocols and expert analysis of results are followed, but "ground truth" as a consensus of clinical experts is not relevant.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

    This is not applicable. Adjudication methods are typically used in clinical studies or for diagnostic evaluations where multiple human readers assess cases. The studies described are laboratory-based biocompatibility and microbiology tests, which follow standardized testing procedures rather than human expert adjudication of results from a "test set" in the clinical sense.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. MRMC studies are specifically for evaluating diagnostic devices, often AI-powered, where human readers interact with or without AI assistance. This device is a tampon, not a diagnostic tool, and involves no AI component or human reader interpretation for its function.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is not applicable, as there is no algorithm or AI component in this device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for the non-clinical performance tests for this device is based on standardized laboratory testing protocols and established scientific criteria for biocompatibility and microbiological safety. For example, for Staphylococcus aureus growth, the ground truth is "does not enhance growth," which is determined by comparing growth in the presence of the tampon to a control, according to established microbiological methods.

    8. The sample size for the training set

    This is not applicable, as there is no training set for an AI/algorithm-driven device.

    9. How the ground truth for the training set was established

    This is not applicable, as there is no training set for an AI/algorithm-driven device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K132819
    Date Cleared
    2013-10-09

    (30 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    Fresh Balance™ Tampons Playtex® (Unscented) Sport Fresh Balance™ Tampons Regulation Number: 21 CFR§ 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Playtex scented (or scented deodorized) and unscented menstrual tampons are intended to be inserted into the vagina and used to absorb menstrual fluid.
    Absorbency Ranges:
    Absorbs menstrual flow

    Device Description

    Scented (or scented deodorized) and unscented menstrual tampons for the absorption of menstrual fluid. The tampon consists of a pledget, string and applicator (barrel and plunger).

    AI/ML Overview

    The provided text is related to a 510(k) submission for menstrual tampons, specifically regarding a change in the applicator color. It is not an AI/ML device, and therefore, most of the requested information regarding acceptance criteria, study details, sample sizes, expert ground truth, MRMC studies, or standalone algorithm performance is not applicable.

    However, I can extract the relevant "acceptance criteria" and the "study" that proves the device meets them from the document in the context of this specific regulatory submission.

    1. A table of acceptance criteria and the reported device performance

    Acceptance Criteria (Implicit from Submission Goal)Reported Device Performance/Conclusion
    Safety: No adverse impact on safety due to applicator color change.Risk Assessment & Leaching Studies: "As confirmed by our risk assessment and leaching studies, the proposed modification on the applicator colorant has no impact on the safety... of the device." (Conclusion) Additionally, "Biocompatibility Tests: Deemed not applicable for the modified device based on the results of the Leaching Studies. Biocompatibility testing was performed on the predicate device to confirm the tampon material safety."
    Efficacy: No adverse impact on efficacy (absorbency) due to applicator color change.Syngyna Testing: "No changes were made to the tampon pledget. Syngyna testing was performed and the results confirmed that the absorbance ranges are the same as the predicate device and comply with 21 CFR §801.430(f)(2)." (Performance Testing) "As confirmed by our risk assessment... the proposed modification on the applicator colorant has no impact on the... efficacy of the device." (Conclusion)
    Substantial Equivalence: Device remains substantially equivalent to the predicate device.Conclusion: "The proposed device is substantially equivalent to the predicate device."

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not applicable as this is a regulatory submission for a physical medical device (menstrual tampon) with a minor change (applicator color), not an AI/ML device relying on test sets of data. The "tests" mentioned are laboratory tests (Leaching Studies, Syngyna testing) performed on the device itself or its materials, not on a data set.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not applicable. Ground truth, in the context of expert consensus, is relevant for AI/ML diagnostic or measurement devices. For this physical device, "ground truth" refers to established scientific/regulatory standards for material safety and absorbency, measured through laboratory methods, not expert interpretation of data.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable. Adjudication methods are typically used in clinical trials or studies for AI/ML devices or human reader performance. The studies performed here are laboratory tests.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable. MRMC studies are specific to evaluating the impact of AI on human reader performance, which is not relevant for a menstrual tampon.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This information is not applicable. There is no algorithm involved in the performance or evaluation of this menstrual tampon.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" in this context is based on established regulatory standards and scientific methodologies for biocompatibility (evaluated through leaching studies, indirectly confirming safety) and absorbency (Syngyna testing against 21 CFR §801.430(f)(2)). It's not based on expert consensus, pathology, or outcomes data in the way these terms are used for AI/ML devices.

    8. The sample size for the training set

    This information is not applicable. There is no AI/ML algorithm requiring a training set for this device.

    9. How the ground truth for the training set was established

    This information is not applicable. Since there is no training set, there's no ground truth to establish for it.

    Ask a Question

    Ask a specific question about this device

    K Number
    K120245
    Manufacturer
    Date Cleared
    2012-06-21

    (146 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    K120245

    Trade/Device Name: Playtex® Gentle Glide Scented & Unscented Tampons Regulation Number: 21 CFR§ 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Playtex® Gentle Glide Scented menstrual tampons are intended to be inserted into the vagina and used to absorb menstrual fluid.

    Playtex® Gentle Glide Unscented menstrual tampons are intended to be inserted into the vagina and used to absorb menstrual fluid.

    Absorbency Ranges:

    Absorbs menstrual flow

    Device Description

    Scented or scented deodorized, unscented menstrual tampons for the absorption of menstrual fluid.

    AI/ML Overview

    The Playtex® Gentle Glide Scented and Unscented Tampons (K120245) have specific acceptance criteria related to absorbency, which were verified through performance testing.

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Absorbency Range per 21 CFR §801.430(f)(2))Reported Device Performance (Absorbency Grams)
    Slender Light
    Ask a Question

    Ask a specific question about this device

    K Number
    K111684
    Date Cleared
    2012-02-03

    (233 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    | | |
    | Regulation Number | § 884.5460
    Re: K111684

    Trade/Device Name: Playtex Sport (Scented) with OdorShield™ Regulation Number: 21 CFR§ 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Playtex scented or scented deodorized menstrual tampons are intended to be inserted into the vagina and used to absorb menstrual fluid; Playtex unscented menstrual tampons are intended to be inserted into the vagina and used to absorb menstrual fluid.

    Device Description

    Scented or scented deodorized, unscented menstrual tampons for the absorption of menstrual fluid.

    AI/ML Overview

    This document describes the regulatory submission for Playtex Sport Tampons with OdorShield™, not a medical device that uses artificial intelligence or requires a clinical study with image data. Therefore, many of the requested categories for AI/clinical study information are not applicable.

    Here's an analysis based on the provided text:

    Device: Playtex Sport (Unscented/Scented) Tampons with OdorShield™

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategoryAcceptance CriteriaReported Device Performance
    Biocompatibility- Cytotoxicity: ISO Agar Overlay- Evaluated according to FDA guidance and applicable standards. Results indicate compliance.
    - Sensitization: Human Repeat Insult Patch Test- Test articles (polar and non-polar extracts) evaluated for sensitization potential under occlusion (9 patch induction, 2-week rest, challenge, 72-hour monitoring) on a panel of women. Results indicate compliance.
    - Irritation & Acute Systemic Toxicity: Human Vaginal Irritation Study- Both scented and unscented tampons provided to a panel of women over 2 menstrual cycles in a randomized double-blind study. Expert assessments (colposcopy) made at baseline, midpoint, and termination indicated compliance.
    Microbiology- Zone of Inhibition- Testing conducted. Results indicate compliance.
    - TSST-1 Testing- Results indicate compliance.
    Odor Absorption- Testing to demonstrate effectiveness of OdorShield™ Technology- Expert panel assessment on OdorShield™ Technology performed.
    - Validated in consumer testing. (Specific quantitative results not provided in the summary, but implied to meet acceptance.)
    Absorbency (Syngyna Testing per 21 CFR 801.430(f)(2))- Regular: Absorbs 6-9 grams of menstrual flow- Syngyna testing conducted. Playtex Sport Regular tampons met the absorbency range of 6-9 grams. The tampons are labeled in accordance with these ranges.
    - Super: Absorbs 9-12 grams of menstrual flow- Syngyna testing conducted. Playtex Sport Super tampons met the absorbency range of 9-12 grams. The tampons are labeled in accordance with these ranges.
    - Super Plus: Absorbs 12-15 grams of menstrual flow- Syngyna testing conducted. Playtex Sport Super Plus tampons met the absorbency range of 12-15 grams. The tampons are labeled in accordance with these ranges.
    Overall Substantial Equivalence- The new tampon has the same technological characteristics as the predicate device (K060981) and the odor absorbing technology is already used in a currently marketed device (K070745). The only difference is the modified use of the odor absorbing technology.- "Results of performance testing indicate that the subject tampon is substantially equivalent to the predicate devices." (Implied that all characteristics, including the modified odor absorbing technology, demonstrate equivalence or acceptable performance for safe and effective use.)

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Biocompatibility (Sensitization): A panel of women was used for the Human Repeat Insult Patch Test. Specific number not provided, but the description implies a prospective study involving human subjects.
    • Biocompatibility (Irritation & Acute Systemic Toxicity): A panel of women of appropriate age was provided with tampons over 2 menstrual cycles. Specific number not provided. This was a randomized double-blind study, indicating a prospective design.
    • Odor Absorption: An "expert panel" was used, followed by "consumer testing." Specific sample sizes for both are not provided. The study design (expert panel, consumer testing) suggests prospective data collection.
    • Syngyna Testing: This is an in vitro laboratory test, not involving human subjects. The sample size would refer to the number of tampons tested, which is not specified. Data provenance would be laboratory-based.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Biocompatibility (Irritation & Acute Systemic Toxicity): "Expert assessments were made at baseline, midpoint and termination of study by colposcopy." The number of experts is not specified, but they are implied to be medical professionals capable of performing and interpreting colposcopic exams.
    • Odor Absorption: An "expert panel" was used for assessment. The number of experts and their specific qualifications are not provided beyond being an "expert panel."

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    The document does not describe any specific adjudication method like 2+1 or 3+1 for resolving discrepancies in expert assessments. It only mentions "expert assessments" and "expert panel assessment."

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not Applicable. This is a physical product (tampon) and not an AI-powered diagnostic or assistive device. Therefore, no MRMC study or AI assistance evaluation was performed.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not Applicable. This is a physical product and does not involve any algorithms or standalone AI performance.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • Biocompatibility:
      • Sensitization: Human physiological response (skin reaction/sensitization).
      • Irritation & Acute Systemic Toxicity: Medical expert (colposcopy) assessment of vaginal health, and implied absence of acute systemic toxicity symptoms.
    • Microbiology: Laboratory results (Zone of Inhibition, TSST-1 detection thresholds).
    • Odor Absorption: Expert panel consensus and consumer perception.
    • Absorbency (Syngyna): Gravimetric measurements of liquid absorption against established regulatory standards.

    8. The sample size for the training set

    Not Applicable. This is a physical product, not an AI model, so there is no "training set."

    9. How the ground truth for the training set was established

    Not Applicable. As there is no training set, this question is not relevant.

    Ask a Question

    Ask a specific question about this device

    K Number
    K102445
    Manufacturer
    Date Cleared
    2010-11-10

    (76 days)

    Product Code
    Regulation Number
    884.5470
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    They are Class II devices, 21 CFR 884.5460 and 21 CFR 884.5470.
    Unscented menstrual tampon & Scented menstrual tampon), regulation number (21 CFR 884.5470 & 21 CFR 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Rostan Scented and Unscented Biodegradable Plastic Applicator Tampons are inserted into the vagina and used to absorb menstrual or other vaginal discharge.

    Device Description

    Rostam plastic scented and unscented biodegradable applicator tampons are being submitted to obtain clearance for a new material applicator. They are menstrual tampons used to absorb menstrual fluid. These Tanıpons will be provided with 4 absorbencies, light, regular, super and super plus.

    These Tampons are made from rayon and/or cotton (as the absorbent material) polymeric overwrap, cotton/polyester sewing thread and cotton cord.

    AI/ML Overview

    The provided text is a 510(k) summary for a menstrual tampon device. It discusses the device's substantial equivalence to previously marketed tampons and includes information about performance testing related to biocompatibility and absorbency. However, it does not describe any acceptance criteria for an AI/ML powered device, nor does it detail a study that proves a device meets such criteria. Therefore, I cannot extract the requested information.

    The document pertains to a traditional medical device (menstrual tampons) and not an AI/ML powered device. The questions in the prompt are specifically geared towards the evaluation of AI/ML medical devices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K091281
    Date Cleared
    2010-06-01

    (396 days)

    Product Code
    Regulation Number
    884.5470
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    2010

    Re: K091281

    Trade Name: Tampax Pearl Unscented Menstrual Tampons Regulation Number: 21 CFR §884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    TAMPAX® Pearl Plastic Applicator Unscented Tampons are menstrual tampons that are inserted into the vagina and used to absorb menstrual fluid.

    Device Description

    The device is a conventional unscented menstrual tampon consisting of an absorbent pledget, an overwrap, a withdrawal cord, an absorbent braid, and an applicator.

    AI/ML Overview

    This document provides a 510(k) summary for the TAMPAX® Pearl Plastic Applicator Unscented Tampons. The purpose of this summary is to demonstrate the device's substantial equivalence to predicate devices, focusing on safety and effectiveness.

    Here’s an analysis of the provided information, framed by your requested criteria:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategoryDescription of Acceptance CriteriaReported Device Performance
    Safety - ToxicologyCompliance with FDA guidance and applicable standards for irritation testing, sensitization testing, acute toxicity, and cytotoxicity.Favorable safety outcomes reported from preclinical toxicology testing. Specific results (e.g., irritation score thresholds) are not provided, but the conclusion is that the device met the safety requirements in these areas.
    Safety - MicrobiologyNo impact on the growth of Staphylococcus aureus; no impact on normal vaginal microflora; no increase in the production of TSST-1 (Toxic Shock Syndrome Toxin-1).Preclinical microbiology testing confirmed that the device "does not impact the growth of Staphylococcus aureus or the normal vaginal microflora, nor does it increase the production of TSST-1."
    Safety - Clinical Adverse EventsAbsence of adverse events related to the test products during clinical trials."In the clinical trials that were performed, no adverse events related to the test products were reported."
    Effectiveness - AbsorbencyCompliance with the syngyna absorbency requirements of 21 CFR 801.430. This regulation defines the standard laboratory test for determining the absorbency of menstrual tampons."TAMPAX® Pearl Plastic Applicator Unscented Tampons comply with the syngyna absorbency requirements of 21 CFR 801.430." The report explicitly states, "Therefore, additional testing of these tampons is not necessary to establish their equivalence to the predicate tampons in terms of effectiveness." This indicates that the device met the regulatory absorbency standard.
    Substantial Equivalence (Overall)The device is equally as safe and effective as the predicate devices in terms of component materials, overall design, intended use, labeling, and performance. The primary change in the 510(k) device is the incorporation of a process aid to decrease microwave setting time for the pledget, which should not affect safety or effectiveness.The submission concludes that "The results of evaluations of this device support the conclusions that it is safe for its intended use and that it is substantially equivalent to the cited predicate devices with regard to safety and effectiveness." The FDA's 510(k) clearance letter confirms this substantial equivalence determination.

    Since this is a 510(k) summary for a menstrual tampon, the "AI" related questions are not applicable to this type of medical device submission. The device described does not involve AI, image analysis, or expert-driven diagnostic interpretations. Therefore, sections 2-6 and 8-9 are specifically tailored to human-read diagnostic studies or AI-driven medical devices and cannot be fully answered or are entirely irrelevant for this tampon submission.

    2. Sample Size Used for the Test Set and Data Provenance

    • Test Set (Clinical Trials): The exact sample size for the clinical trials is not specified in the provided text. The document states "In the clinical trials that were performed..." but does not give numerical details about participants.
    • Data Provenance: The document does not specify the country of origin of the data. It implies prospective clinical evaluations ("clinical trials that were performed").
    • Preclinical Testing: No sample sizes are provided for the preclinical toxicology or microbiology testing.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Not Applicable. This is a physical medical device (tampon), not a diagnostic device requiring expert interpretation or ground truth establishment in the traditional sense of image analysis or diagnostic studies. The safety and effectiveness are assessed through laboratory tests and clinical observations rather than expert consensus on a diagnostic output.

    4. Adjudication Method for the Test Set

    • Not Applicable. As above, this is not a diagnostic study requiring adjudication of expert opinions. Clinical observations were made during trials, and laboratory tests were conducted, but an adjudication method for a "test set" in the context of interpretation is not relevant here.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not Applicable. This is not a diagnostic device, and therefore neither an MRMC study nor AI assistance is relevant.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not Applicable. This device does not involve an algorithm or AI.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    For this device, "ground truth" is established through:

    • Standardized Laboratory Testing: For absorbency, the syngyna absorbency test (21 CFR 801.430) serves as the defined standard. For toxicology and microbiology, standard methods are used to determine parameters like irritation, sensitization, and microbial growth/toxin production. These are objective measures against predefined criteria.
    • Clinical Observation: Absence of adverse events in clinical trials serves as "ground truth" for clinical safety, relying on participant reporting and investigator observation.
    • Comparison to Predicate: The ultimate "ground truth" for substantial equivalence is that the new device performs equivalently to the legally marketed predicate devices, as demonstrated by the above tests.

    8. The sample size for the training set

    • Not Applicable. This device does not involve an algorithm or AI, so there is no "training set."

    9. How the ground truth for the training set was established

    • Not Applicable. This device does not involve an algorithm or AI, so there is no "training set" and therefore no ground truth established for it.
    Ask a Question

    Ask a specific question about this device

    K Number
    K090071
    Manufacturer
    Date Cleared
    2009-05-28

    (136 days)

    Product Code
    Regulation Number
    884.5470
    Reference & Predicate Devices
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    Device Name: Rostam Fragranced and Unfragranced Compact Applicator Tampons Regulation Number: 21 CFR §884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Rostam Fragranced and Unfragranced Compact Applicator Tampons are inserted into the vagina and used to absorb menstrual or other vaginal discharge

    Device Description

    Rostam plastic applicator tampons are menstrual tampons used to absorb menstrual fluid. These Tampons will be provided with 3 absorbencies, Light, regular and super. These Tampons are made from rayon and/or cotton polymeric overwrap and cotton cord. The materials used in these tampons are similar to those used in other legally marketed tampons.

    AI/ML Overview

    The provided text is for a 510(k) summary for a medical device (tampons). The purpose of a 510(k) summary is to demonstrate substantial equivalence to a legally marketed predicate device, not necessarily to detail comprehensive device-specific performance studies with specific acceptance criteria and detailed study designs as might be found for novel, higher-risk devices.

    Based on the provided text, here's what can be extracted regarding acceptance criteria and studies:

    1. Table of Acceptance Criteria and Reported Device Performance:

    Acceptance CriteriaReported Device Performance
    Biocompatibility/Safety EquivalenceDemonstrated that tampons are equivalent in terms of safety and effectiveness to legally marketed tampons based on historical testing and review of existing toxicological data.
    AbsorbencyConfirmed by Standard Syngyna testing.
    Irritation/SensitizationRepeated Insult Patch Test on 100 human subjects showed acceptable results (implied by overall safety claim).

    2. Sample Size Used for the Test Set and Data Provenance:

    • Repeated Insult Patch Test: 100 human subjects.
    • Data Provenance: Not explicitly stated for all tests, but "review of existing toxicological data in the public literature" suggests some data is retrospective and potentially sourced broadly. The human patch test is prospective. No country of origin is specified.
    • Syngyna Testing: No explicit sample size specified, as it's a standardized in vitro test.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:

    • The document does not mention experts being used to establish "ground truth" in the context of diagnostic performance or clinical outcomes. The assessments are primarily for safety and absorbency, which are typically evaluated by laboratory analysis or clinical safety studies, not expert consensus on ground truth in a diagnostic sense. For the patch test, the evaluation would be performed by trained dermatologists or clinicians, but the number is not specified.

    4. Adjudication Method for the Test Set:

    • Not applicable/Not mentioned. Adjudication methods are typically relevant for studies where multiple readers assess cases against a predefined ground truth, which is not the primary focus here.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

    • No. This type of study is not relevant for tampons, as they are not diagnostic devices that involve human readers interpreting results.

    6. Standalone Performance Study (Algorithm Only):

    • No. This is not applicable. Tampons are not an algorithm-based device.

    7. Type of Ground Truth Used:

    • Biocompatibility/Safety: Historical testing data, literature review, and direct results (e.g., lack of significant skin reactions in the patch test).
    • Absorbency: Standardized laboratory measurements (Syngyna test) which serve as the "ground truth" for absorbency.

    8. Sample Size for the Training Set:

    • Not applicable. As this device is not an AI/ML diagnostic or image interpretation device, there is no "training set." The reference to "historical data" and "public literature" for safety serves a similar purpose to a knowledge base, but not a supervised machine learning training set.

    9. How the Ground Truth for the Training Set Was Established:

    • Not applicable, as there is no training set as defined in an AI/ML context.

    Summary of Approach:

    The K096671 submission for Rostam tampons primarily relies on demonstrating substantial equivalence to a previously legally marketed device (Tampax Compak Pearl Scented and unscented Tampons). This means the focus is on showing that the new device has the same intended use, similar technological characteristics, and raises no new questions of safety or effectiveness.

    The "studies" mentioned (Biocompatibility testing, Syngyna testing, Repeated Insult Patch Test) are primarily to confirm the safety and functional performance (absorbency) in a manner consistent with established standards for tampons and to demonstrate they meet the safety profile of predicate devices. The phrase "these Tampons are equivalent in terms of safety and effectiveness to legally marketed tampons" is the overarching "acceptance criterion" met by the provided test results.

    Ask a Question

    Ask a specific question about this device

    K Number
    K081555
    Date Cleared
    2008-06-27

    (24 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    Unscented menstrual tampon (21 CFR 884.5470)
    Scented or scented deodorized menstrual tampon
    (21 CFR 884.5460
    Re: K081555

    Trade Name: TAMPAX® Pearl Plastic Tampons (Scented and Unscented) Regulation Number: 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The TAMPAX® Pearl Plastic™ unscented and scented Tampons are intended to be inserted into the vagina to absorb menstrual fluid.

    Device Description

    Scented or scented deodorized, unscented menstrual tampons for absorption of menstrual fluid.

    AI/ML Overview

    This document is a 510(k) summary for a medical device (TAMPAX® Pearl Tampons) seeking clearance from the FDA. The information provided focuses on demonstrating substantial equivalence to predicate devices, rather than presenting a performance study with detailed acceptance criteria and results.

    Therefore, many of the requested sections regarding acceptance criteria, study details, and AI-specific metrics cannot be extracted from the provided text. The document primarily describes the device, its intended use, and a safety assessment, then states conclusions about its safety and substantial equivalence to existing products.

    Here's a breakdown of what can and cannot be answered:

    1. A table of acceptance criteria and the reported device performance

    • Cannot be provided in the requested format. The document does not describe specific numerical acceptance criteria (e.g., sensitivity, specificity, accuracy thresholds) or corresponding quantitative device performance metrics in the way a diagnostic AI study would.
    • What is stated: "The results of these safety tests support the conclusion that the 510(k) device is equally as safe as the predicate devices." and "The device is designed to acquire and hold menstrual fluids similar to the fluid handling capabilities of the predicate devices." This indicates a qualitative comparison for safety and functionality rather than quantitative performance against a set of predefined thresholds.

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Not explicitly stated for a "test set" in the context of device performance. The document mentions "in vitro microbiological testing, biocompatibility evaluation and extraction testing" as part of the safety assessment. However, it does not specify sample sizes or data provenance (country, retrospective/prospective) for these tests in a way that aligns with evaluating a device's diagnostic performance against a ground truth.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    • Not applicable/Not stated. This type of information is relevant for studies validating diagnostic algorithms where expert consensus or pathological analysis establishes ground truth. For a menstrual tampon, the "ground truth" would likely relate to material properties, absorbency, and safety markers, which are evaluated through lab tests, not expert interpretation of outputs.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not applicable/Not stated. Adjudication methods are used in studies involving human interpretation or subjective assessments, typically for diagnostic image analysis or similar tasks. This is not described for a tampon.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not applicable. This device is a menstrual tampon, not an AI-powered diagnostic tool. Therefore, a multi-reader multi-case comparative effectiveness study involving human readers and AI assistance is not relevant and was not performed.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    • Not applicable. This is not an algorithm or AI device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • Implied ground truth for safety and function: The "ground truth" for this device would be established through laboratory testing standards for absorbency, material composition, biocompatibility, and microbiological safety. The document refers to "in vitro microbiological testing, biocompatibility evaluation and extraction testing." These tests have their own established methods and criteria for determining safety and performance, which serve as the "ground truth" for evaluating the tampon's characteristics.

    8. The sample size for the training set

    • Not applicable. This is not an AI/ML device that requires a training set.

    9. How the ground truth for the training set was established

    • Not applicable. This is not an AI/ML device that requires a training set.

    Summary of what the document does provide regarding the device and its assessment:

    The document describes the submission of a 510(k) premarket notification for TAMPAX® Pearl Tampons (unscented and scented). The primary goal of this submission is to demonstrate substantial equivalence to predicate devices (TAMPAX Pearl Tampons® unscented and scented: K011996; K040312; K051290).

    Key "Acceptance Criteria" (implicit, based on 510(k) process for this device type):

    • Safety: The device is as safe as predicate devices.
    • Effectiveness/Functionality: The device is designed to acquire and hold menstrual fluids similar to the fluid handling capabilities of the predicate devices.
    • Technological Characteristics: The device is similar to the predicate devices in terms of basic component materials, overall design, and labeling.
    • Intended Use: Consistent with predicate devices.

    Study that proves the device meets the (implicit) acceptance criteria:

    • Study Type: A battery of safety evaluations was conducted.
    • Specific Tests Mentioned:
      • In vitro microbiological testing
      • Biocompatibility evaluation
      • Extraction testing
    • Results/Conclusions:
      • "The results of these safety tests support the conclusion that the 510(k) device is equally as safe as the predicate devices."
      • "The results of evaluations for this device support the conclusions that it is safe for its intended use and substantially equivalent to the cited predicate devices."

    In conclusion, this document describes a traditional medical device submission (a tampon) seeking clearance based on substantial equivalence, not a performance study for an AI-driven diagnostic device. Therefore, the detailed metrics and study design elements typically associated with AI performance evaluation are not present.

    Ask a Question

    Ask a specific question about this device

    K Number
    K073662
    Date Cleared
    2008-01-17

    (22 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    . § 884.5460 and HEB, § 884.5470,
    respectively). |

    Legally Marketed (Unmodified) Devices:

    Playtex
    K073662

    Trade/Device Name: Playtex Gentle Glide and Playtex Multipack Tampons Regulation Number: 21 CFR 884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Scented or scented deodorized menstrual tampon for the absorption of menstrual fluid; unscented menstrual tampon for the absorption of menstrual fluid.

    Device Description

    Scented or scented deodorized, unscented menstrual tampons for the absorption of menstrual fluid.

    AI/ML Overview

    This 510(k) summary is for a menstrual tampon, not a medical device that uses AI or requires complex statistical studies for its approval. Therefore, many of the requested categories regarding acceptance criteria and study design for AI/medical imaging devices are not applicable.

    Here's the information that can be extracted and a clear indication of why other sections are not relevant to this specific premarket notification:

    Acceptance Criteria and Device Performance for Playtex Gentle Glide Tampons

    Acceptance Criteria (from "Performance Data")Reported Device Performance
    Cytotoxicity testing: (Implied: Device must not exhibit cytotoxic effects)"Cytotoxicity testing...indicate that the modified device meets all device input requirements." (Implies satisfactory performance, absence of cytotoxicity)
    Acute systemic toxicity testing: (Implied: Device must not cause acute systemic toxic effects)"acute systemic toxicity testing...indicate that the modified device meets all device input requirements." (Implies satisfactory performance, absence of acute systemic toxicity)
    Vaginal irritation testing: (Implied: Device must not cause vaginal irritation)"vaginal irritation testing...indicate that the modified device meets all device input requirements." (Implies satisfactory performance, absence of vaginal irritation)
    Allergic contact sensitization tests: (Implied: Device must not cause allergic contact sensitization)"allergic contact sensitization tests...indicate that the modified device meets all device input requirements." (Implies satisfactory performance, absence of allergic contact sensitization)
    Microbial agar diffusion: (Implied: Device must not promote microbial growth or conversely, may need to demonstrate inhibitory properties if claimed, though typically it's about biocompatibility)"microbial agar diffusion...indicate that the modified device meets all device input requirements." (Implies satisfactory performance related to microbial interaction, consistent with safe use)
    Toxic Shock Syndrome Toxin-1 (TSST-1) testing: (Implied: Device must meet safety standards regarding TSST-1 production, typically by not enhancing its production or having low/negligible impact. This is a critical safety aspect for tampons.)"toxic shock syndrome toxin-1 (TSST-1) testing indicate that the modified device meets all device input requirements." (Implies satisfactory performance, consistent with safety standards for TSST-1, which is a key regulatory requirement for tampons.)

    Note on "Device Input Requirements": The document states the device "meets all device input requirements." These "input requirements" would be the specific pass/fail criteria for each test (e.g., cytotoxicity score below a certain threshold, no irritation observed, TSST-1 production not significantly increased, etc.). The 510(k) summary only states that these requirements were met, not the specific numerical thresholds themselves.


    Non-Applicable Sections and Explanations:

    Due to the nature of this device (a menstrual tampon), the following information is not provided and is generally not relevant for this type of medical device submission:

    1. Sample size used for the test set and the data provenance: Not specified for biocompatibility/safety tests. These tests are typically conducted in vitro or on animal models, not on large human "test sets" in the way an AI algorithm is evaluated.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. Ground truth as typically understood in AI/imaging studies (e.g., expert radiological reads) is not relevant for tampon safety testing. Biocompatibility tests rely on standardized laboratory protocols and scientific evaluation.
    3. Adjudication method: Not applicable for standard biocompatibility and safety testing. The results are typically objectively measured and interpreted by laboratory personnel.
    4. Multi-reader multi-case (MRMC) comparative effectiveness study: Not applicable. This type of study assesses how AI impacts human reader performance, which doesn't apply to a physical product like a tampon.
    5. Standalone performance (algorithm only without human-in-the-loop performance): Not applicable, as there is no algorithm or human-in-the-loop component for a tampon.
    6. The type of ground truth used: For these safety tests, the "ground truth" is established via standardized biological and chemical assay results (e.g., cell viability percentages for cytotoxicity, observed tissue reactions for irritation, quantitative measurements for TSST-1). It's not "expert consensus, pathology, or outcomes data" in the context of an AI/imaging device.
    7. The sample size for the training set: Not applicable. There is no AI model or "training set" for a menstrual tampon.
    8. How the ground truth for the training set was established: Not applicable, as there is no training set.

    Summary of the Device and Basis for Substantial Equivalence:

    The Playtex Gentle Glide and Playtex Gentle Glide Multipack Tampons are seeking substantial equivalence to previously cleared Playtex tampons (K961870 and K070745). The submission emphasizes that the new tampon has the "same technological characteristics" and that "The fiber, string, and materials in contact with the vaginal wall are the same or have the same mode of action." The primary differences are noted as "the absorbency (lower), the dimensions of the unformed pledget pads, and the dimensions of the final formed pledget."

    The "Performance Data" section demonstrates that despite these minor changes, the modified device still meets established safety and biocompatibility standards, specifically citing:

    • Cytotoxicity testing
    • Acute systemic toxicity testing
    • Vaginal irritation testing
    • Allergic contact sensitization tests
    • Microbial agar diffusion
    • Toxic Shock Syndrome Toxin-1 (TSST-1) testing

    The conclusion is that based on these results, the modified Playtex tampon is substantially equivalent to the predicate tampons, meaning it is as safe and effective as the legally marketed devices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K072376
    Date Cleared
    2007-12-12

    (110 days)

    Product Code
    Regulation Number
    884.5460
    Reference & Predicate Devices
    Why did this record match?
    510k Summary Text (Full-text Search) :

    . § 884.5460 and HEB, § 884.5470,
    respectively). |

    510(k) SUMMARY

    Legally Marketed (Unmodified

    Trade Name: Playtex Gentle Glide and Playtex Gentle Glide Multipack Tampons Regulation Number: 21 CFR §884.5460

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Scented or scented deodorized menstrual tampon for the absorption of menstrual fluid; unscented menstrual tampon for the absorption of menstrual fluid.

    Device Description

    Scented or scented deodorized, unscented menstrual tampons for the absorption of menstrual fluid.

    AI/ML Overview

    The provided text describes a 510(k) submission for Playtex Gentle Glide and Playtex Gentle Glide Multipack Tampons. It details the device, its intended use, technological characteristics, and conformity to absorbency regulations. However, it does not contain specific acceptance criteria for a device's performance metrics (like sensitivity, specificity, accuracy) or a study proving that the device meets such criteria in the way typically found for AI/medical imaging devices.

    Instead, the document focuses on demonstrating substantial equivalence to predicate devices, biocompatibility, and compliance with absorbency regulations for tampons.

    Therefore, many of the requested categories cannot be filled as the information is not present in the provided text.

    Here's how the available information maps to your request:

    1. Table of Acceptance Criteria and Reported Device Performance

    Performance Metric CategoryAcceptance Criteria (as per document)Reported Device Performance
    BiocompatibilityAll device input requirements for biocompatibility (Cytotoxicity, acute systemic toxicity, vaginal irritation, dermal irritation, allergic contact sensitization, microbial agar diffusion, TSST-1)."Biocompatibility and Performance Data: Cytotoxicity testing, acute systemic toxicity testing, vaginal irritation testing, dermal irritation, allergic contact sensitization tests, microbial agar diffusion and toxic shock syndrome toxin-1 (TSST-1), and a clinical study [double-blind, randomized, comparative in-use evaluation of tampon products for overall safety and effect on the vaginal micro flora] testing indicate that the modified device meets all device input requirements."
    Absorbency LevelCompliance with "Ultra absorbency" as set forth in 21 C.F.R. § 801.430(e)(1), "User Labeling for Menstrual Tampons.""The new scented and unscented tampons are in compliance with the requirements for Ultra absorbency as set forth in 21 C.F.R. § 801.430(e)(1), 'User Labeling for Menstrual Tampons.'"
    Vaginal Micro FloraOverall safety and effect on the vaginal micro flora (implied to be comparable to predicate devices)."a clinical study [double-blind, randomized, comparative in-use evaluation of tampon products for overall safety and effect on the vaginal micro flora] testing indicate that the modified device meets all device input requirements."

    2. Sample size used for the test set and the data provenance

    • Sample size for test set: Not explicitly stated for biocompatibility or absorbency tests.
    • Data provenance: Not specified (e.g., country of origin). The clinical study is described as a "double-blind, randomized, comparative in-use evaluation." This implies prospective data collection, but no specifics on location or demographics are provided.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not applicable as the device is not an AI/diagnostic device. Ground truth is established through laboratory testing (biocompatibility, absorbency) and clinical observation in the case of the in-use evaluation. No "experts" in the sense of human readers interpreting data are mentioned.

    4. Adjudication method for the test set

    • Not applicable. The tests mentioned (biocompatibility, Syngyna absorbency, clinical in-use evaluation) are not subject to a human adjudication process in the way a diagnostic image interpretation would be.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No MRMC study was conducted or is applicable here. The device is a menstrual tampon, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable. The device is not an AI algorithm.

    7. The type of ground truth used

    • Biocompatibility: Established through standardized in vitro and in vivo laboratory tests (cytotoxicity, systemic toxicity, irritation, sensitization, microbial, TSST-1).
    • Absorbency: Established through the "Syngyna Absorbency Results," which refers to a standardized laboratory test for tampon absorbency as per 21 C.F.R. § 801.430(e)(1).
    • Vaginal Micro Flora/Overall Safety: Established through a "double-blind, randomized, comparative in-use evaluation of tampon products." This would involve clinical observation and potentially laboratory analysis of vaginal microflora samples.

    8. The sample size for the training set

    • Not applicable, as this is not an AI/machine learning device.

    9. How the ground truth for the training set was established

    • Not applicable, as this is not an AI/machine learning device.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 4